Hepatitis News : Long-term Entecavir Is Safe and Effective for Hep B Patients, Even with Cirrhosis
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hepatitis E-newsletter
Join Us:

Back to home » Hepatitis News » November 2012


November 30, 2012

Long-term Entecavir Is Safe and Effective for Hep B Patients, Even with Cirrhosis

Entecavir has shown safety and efficacy over a five-year period in people with hepatitis B who haven’t yet tried treatment with nucleos(t)ide analogues,(NUC), according to the National AIDS Treatment Advocacy Project. The medication even showed promise in those with cirrhosis. Italian researchers presented results from a study of the nucleos(t)ide analogue at the annual meeting of the American Academy for the Study of Liver Diseases (AASLD) in Boston.

One study enrolled 418 NUC-naive patients with chronic hepatitis B virus (HBV) in 19 Italian health centers. All patients took entecavir monotherapy. Researchers monitored them with an HBV viral load test and a screen for resistance to entecavir every three to six months during 60 months of follow-up. Among the cohort, 204 (49 percent) had cirrhosis and 41 (10 percent) had hepatocellular carcinoma (HCC), the most common form of liver cancer. At baseline, none in the cohort had an undetectable viral load. By six months, 67 percent were undetectable; by one year, 85 percent; and by five years, 100 percent. Only one patient developed resistance to the drug. Long-term use of entecavir in patients with cirrhosis prevented decompensation of the liver, but not liver cancer.
To read study slides from AASLD, click here

Search: Hepatitis B, HBV, virus, entecavir, nuscleos(t)ide analogue, NUC, American Academy for the Study of Liver Diseases, AASLD, hepatoceullar carcinoma, HCC, liver cancer, decompensation, viral load, undetectable.

Scroll down to comment on this story. Click here to visit the Hep Forums and ask questions about this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The Hep team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Quick Links
Current Issue
Hep TV
Services Directory
Conference News
Top Stories
Treatment News
Hep Exclusives
All About Hepatitis
• Hepatitis A
• Hepatitis B
• Hepatitis C
HCV/HIV Coinfection
Help Paying For Meds
Clinical Trials
Tell us what you think
Do you know any young people (under age 30) who are currently living with hepatitis C?

Hepatitis C Reader Survey
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.